25-11-2021 | Online | Online (Online)
16:00 - 16:15 Welcome to the XVth CONGRESS of the SCI
| Presentador/a: Pablo Engel Rocamora
|
|
|
16:15 - 17:00 Opening Lecture:
| Ponent: Friedrich Koch-Nolte
|
|
|
| Moderador/a: Pablo Engel Rocamora
|
|
|
17:00 - 17:30 Company sponsored session Becton Dickinson
Flow Cytometric Monitoring of Anti CD 20 Therapies
17:30 - 18:00 Plenary Session - Cord blood as a starting material for advanced therapies
| Moderador/a: Ramón Gimeno
|
|
|
| Ponent: Sergi Querol Giner
|
|
|
18:00 - 20:00 Oral Communications I Basic Experimental Immunology
| Moderador/a: Jose Aramburu
|
|
|
| Moderador/a: Francisco Lozano Soto
|
|
|
OC1 IRF 1 is required for MDA 5 (IFIH 1 induction by IFN a, LPS and poly(I C) in murine macrophages Carlos
OC 2 NK cells eliminate Epstein Barr virus bound to B cells through a specific antibody mediated uptake
OC 3 Enforced sialyl Lewis X sLeX display in E selectin ligands by exofucosylation is dispensable for CD 19 CAR T cell activity and bone marrow homing.
OC 4 HEK 293 F cell line shows different antigen presentation features than HEK 293
26-11-2021 | Online | Online (Online)
09:00 - 09:30 Plenary Session - Advanced immunotherapies for the management of complications post hematopoietic stem cell transplant Multiple uses of mesenquimal cells
| Moderador/a: Francesc Rudilla
|
|
|
| Ponent: joaquim Vives Armengol
|
|
|
09:30 - 11:30 Oral Communications II Autoimmunity and Clinical Immunology
| Moderador/a: Clara Franco Jarava
|
|
|
| Moderador/a: Odette Viñas
|
|
|
OC 5 Association of HLA B* 35 and severe hypersensitivity reactions secondary to benznidazole treatment in chronic Chagas disease patients.
OC 6 Limitations of commercial assays as diagnostic tests of autoimmune encephalitis.
OC 7 Dacmecitos study Influence of the type of donation on the inflammatory pattern in lung transplantation.
| Ponent: Alberto Sandiumenge Camps
|
|
|
OC 8 Anti Th/To auto antibodies in patients with SSc are the commercial assays good enough?
OC 9 Interaction between humoral and cutaneous immune response to Candida albicans in plaque psoriasis.
| Ponent: Lídia Sans de San Nicolás
|
|
|
OC 10 Peripheral Blood Lymphocyte Subsets at diagnosis of Arthritis in the Elderly differences between elderly onset rheumatoid arthritis and polymyalgia rheumatic.
| Ponent: Aina Teniente Serra
|
|
|
11:30 - 12:00 Plenary Session - Advanced immunotherapies for the management of complications post hematopoietic stem cell transplant Multiple uses of mesenquimal cells
| Moderador/a: Carles Serra
|
|
|
12:00 - 12:45 Company sponsored lunch session I Beckman Coulter
Unmasked Targets, Retired Pipettes, Uncharged Sorting And Other Beckman Coulter Innovations In Flow Cytometry
12:45 - 13:15 Company sponsored lunch session II Miltenyi Biotec
Identification of CAR target candidates against pancreatic adenocarcinoma using ultra high content imaging
13:15 - 14:15 Ordinary General Meeting Societat Catalana d’Immunologia
14:15 - 16:30 Oral Communications III Tumor Immunology Immunotherapy
| Moderador/a: Sonia Guedan
|
|
|
OC 11 MYC inhibition by an Omomyc based therapy abrogates tumor progression and induces immune cell recruitment in models of NSCLC.
| Ponent: Sílvia Casacuberta
|
|
|
OC 12 ARI 0001 autorització sota exempció Hospitalària com emprar productes d'immunoteràpia autoritzats després d'un assaig clínic exitòs.
OC 13 Optimizing a FAP CAR T cell for clinical trials.
OC 14 Pre leukemic CD 34 +CD 19 CD 22 early B cell progenitors might underlie phenotypic escape in patients treated with CD 19 directed immunotherapies.
OC 15 A novel and efficient tandem CD 19 and CD 22 directed CAR for B cell ALL.
OC 16 DIF peptides, a new approach to cancer immunotherapy Preliminary studies.
OC 17 CD 137 costimulation counteracts TGF B inhibition of NK cell anti tumor function.
| Ponent: Aura Muntasell et
|
|
|
15:55 - 16:30 Discussion
16:45 - 19:00 Oral Communications IV COVID 19
| Moderador/a: Jorge Carrillo
|
|
|
| Moderador/a: Gemma Moncunill
|
|
|
OC 18 SARS CoV 2 sculpts the immune system to induce sustained virus specific naïve like and memory B cell responses.
OC 19 Clinical course impacts early kinetics and long term magnitude and amplitude of SARS CoV 2 neutralizing antibodies beyond one year after infection.
OC 20 Determinants of early antibody responses to COVID 19 mRNA vaccines in exposed and naive healthcare workers.
OC 21 A new flow cytometry cell based assay to efficiently determine RBD specific neutralization of SARS CoV 2 emerging variants.
OC 22 Analysis of Clinical and Laboratory Markers Based on the First COVID 19 Wave in Barcelona Limitations of the Current Clinicopathological Tests Guides the Identification of Effective Biomarkers.
| Ponent: Ricardo Pujol Borrell
|
|
|
OC 23 High dose intravenous immunoglobulins might modulate inflammation in COVID 19 patients.
OC 24 SARS CoV 2 antibody kinetics in healthcare workers in northern metropolitan Barcelona.
| Ponent: Marc Boigues Pons
|
|
|
19:00 - 19:30 Plenary Session - Regulatory T cells in Autoimmune diseases
| Ponent: Piotr Trzonzowski
|
|
|
| Moderador/a: Eva Martínez Cáceres
|
|
|
19:30 - 19:45 Prize to the best communication and poster. Closing of the Congress
| Ponent: Eva Martínez Cáceres
|
|
|
Inscripcions
Pòster Congrés